Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01479829 · ClinicalTrials.gov registry record · Phase 4
Cyclooxygenase-2-Inhibitor Combination Treatment for Bipolar Depression
A Phase 4 study, sponsored by Loyola University.
- Completed
- Registry status
- Phase 4
- Development phase
- 100
- Enrollment target
NCT01479829 is a Phase 4 study that has completed, run by Loyola University. The registered enrollment target is 100 participants.
The verdict
NCT01479829, a Phase 4 study, has completed, sponsored by Loyola University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 100 participants
- Enrollment target
Study Summary
This project will attempt to enhance and augment the antidepressant efficacy of a commonly used antidepressant in poorly responding bipolar depressed patients.
Interventions
- DRUG Placebo
- DRUG Escitalopram
- DRUG Celecoxib
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2011-03-23 |
| Est. Completion | 2018-01-24 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01479829
The ClinicalTrials.gov registry entry for NCT01479829 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Loyola University, which has 92 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.
NCT01479829 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01479829 about?
NCT01479829 is a clinical study titled "Cyclooxygenase-2-Inhibitor Combination Treatment for Bipolar Depression". This project will attempt to enhance and augment the antidepressant efficacy of a commonly used antidepressant in poorly responding bipolar depressed patients.
What is the current status of trial NCT01479829?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 100 participants. The study started on 2011-03-23. Estimated completion is 2018-01-24.
What interventions are being tested in trial NCT01479829?
The interventions under investigation include: Placebo (DRUG), Escitalopram (DRUG), Celecoxib (DRUG).
Who is sponsoring clinical trial NCT01479829?
This trial is sponsored by Loyola University, which has 92 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.